GlassScriptPhysician profile
Gabriele Cuna
NPI 1790325686
$4,161.09
in general payments reported to CMS, 2019-2025
9 companies · $799 in 2025
The $799 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.19 · 2022: $786 · 2023: $1,230 · 2024: $1,313 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,829 · Travel and Lodging: $486 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,828.77 |
| Travel and Lodging | $485.60 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,488.90 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Relievant Medsystems, INC. | $1,279.54 | 2022-2023 | Intracept |
| Si-Bone, INC. | $405.15 | 2022-2025 | |
| Nevro Corp. | $333.43 | 2023-2024 | Senza |
| Globus Medical, INC. | $275.92 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $124.97 | 2025 | |
| Paratek Pharmaceuticals, INC. | $123.79 | 2024 | Nuzyra |
| Orthofix Medical, INC. | $95.20 | 2024 | Spinal-Stim |
| Karl Storz Endoscopy-America | $34.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriele Cuna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.